Upload
STAT5 min readSociety
Opinion: Community Engagement Is Key To Clinical Trial Recruitment And Diversity
Two birds, one stone: improving diversity in clinical trials will simultaneously improve participation.
STAT7 min readPolitics
Trump Has Made A Priority Of Trying To Lower Drug Prices. But Many Of His Most Ardent Supporters Don’t Know It
Few of his supporters — even those willing to blast "Big Pharma" or whose ears perked up at the mention of drug importation — had any idea that Trump had…
STAT3 min readSociety
In Bid To Improve Care, Trump Administration To Relax Privacy Rules For Patients With History Of Addiction
The Trump administration on Thursday unveiled a long-awaited proposal to relax privacy requirements for patients with a history of addiction.
STAT4 min readScience
Opinion: Gene Editing To Stop Lyme Disease: Caution Is Warranted
I'm inherently cautious about genetically engineering wild species. but in some cases, it may be relatively safe, beneficial to human health, and worth the presumed risks.
STAT4 min readScience
Opinion: A Community-guided Genome Editing Project Can Fight Lyme Disease
Even if there are differences of opinion about genetically engineering Lyme-resistant mice, ensuring that ecological engineering proposals start small and invite community guidance is a project everyone can support.
STAT10 min readSociety
Can A New Lyme Disease Vaccine Overcome A History Of Distrust And Failure?
As the threat of Lyme disease grows and fears surrounding it spread faster than the ticks that carry the infection, researchers are developing two vaccine or vaccine-like approaches to prevent this increasingly problematic disease. But don’t expect t
STAT4 min readScience
NIH Will Soon Share Genetic Data With Those Who Participated In Precision Medicine Study
The NIH’s landmark “All of Us” precision medicine project is going to share genetic analyses with the first round of participants. It’s an unprecedented step.
STAT5 min readPolitics
Opinion: Trump Is Trying To End Secret Health Care Price Negotiations. You Should Be On His Side
The Trump administration's efforts in health care price transparency should be supported and furthered to help reveal — and begin to repair — cracks in the health care system that…
STAT4 min read
FDA On Novartis Data Manipulation Controversy: ‘We Happened To Be Lucky’
An important lesson from the Novartis data manipulation scandal, a top FDA official said: Providing accurate data is paramount, even if "it may take a little more time to get…
STAT4 min readScience
Scientists Routinely Cure Brain Disorders In Mice But Not Us. A New Study Helps Explain Why
Scientists routinely cure brain disorders in mice but not in humans. A new study helps explain why.
STAT4 min readScience
Opinion: FDA Should Use Its Existing Program To Qualify New Tools For Drug Safety Testing
Integrating into FDA applications qualified drug safety tests based on human biology will mean safer drugs, financial savings, less animal testing, and better medicines.
STAT6 min readSociety
‘Maisie’s Army’: How A Grassroots Group Is Mobilizing To Help Toddlers Access A Lifesaving Drug
A grassroots group called "Maisie's Army" is mobilizing to help toddlers with a rare disease access a lifesaving drug.
STAT2 min read
Endo Agrees To Pay $10 Million To Settle Landmark Opioid Case Brought By Ohio Counties
As a landmark trial over the opioid crisis grows closer, Endo agreed to a $10 million settlement with two Ohio counties that claimed the drug maker inappropriately marketed its addictive…
STAT4 min readSociety
Opinion: Containing The Ebola Outbreak Means Addressing Its Root Causes: A Weak Health System And Insecurity
It's time to treat Ebola like the global health threat it is — and that means addressing the conditions that make any disease too "viral" to contain.
STAT3 min readSociety
Many Clinical Trials For New Cancer Drugs Didn’t Include Any Data On Race
Even when clinical trial data did include information on a patient’s race, the trials had far fewer black and Hispanic participants than expected.
STAT5 min readScience
A Writer Shared Her Story About Getting Frightening Genetic Results Online. The Response Was Surprising
A writer shared her story about getting frightening genetic results online. The response was surprising.
STAT5 min readWellness
Could The World See A Resurgence Of Polio? Experts Fear A Cautionary Tale In Measles
The resurgence of measles has become a cautionary tale — both useful and unsettling — of why the polio campaign must push on across the finish line, officials say.
STAT3 min readScience
Sarepta Stumbles On FDA Rejection Of A New Drug To Treat Duchenne Muscular Dystrophy
Sarepta Therapeutics was dealt a surprising setback when the FDA rejected its application for a second Duchenne muscular dystrophy drug.
STAT2 min read
Top Scientist Categorically Denies Any Wrongdoing In Novartis Data Manipulation Scandal
The Novartis scientist who was ousted by the drug maker in connection with a scandal over data manipulation broke his silence.
STAT4 min readSociety
AIDS Activists Say Gilead Put Profits Over Patients — And Misled Congress About An HIV Pill
AIDS activists say Gilead put profits over patients — and misled Congress about an HIV pill.
STAT2 min read
This Troubled Biotech Needed Cash, So It Turned To A Predatory Lender: Its Own CEO
I don’t write about Northwest Biotherapeutics much anymore because it’s not cool to punch down. However, there was a juicy nugget in the cancer biotech’s recently filed 10-Q that had to be shared. It’s another example of a biotech executive getting r
STAT4 min readSociety
Opinion: Virtual And Augmented Reality Can Save Lives By Improving Surgeons’ Training
Rapid advances in the development of medical devices in the 21st century are contributing to healthier lives, but bring with them a new challenge: teaching clinicians how to use these often-complicated technologies. Teaching them poorly, or failing t
STAT6 min readScience
Top U.S. Medical Centers Roll Out DNA Sequencing Clinics For Healthy (and Often Wealthy) Clients
Top U.S. medical centers are rolling out DNA sequencing clinics for healthy (and often wealthy) clients.
STAT1 min read
Listen: The Serious Side Of Spit Kits, How BiTEs Leave A Mark, & Sarepta’s Sluggish Study
Is anything too weighty to be explained over the internet? Can a new spin on old technology outfox CAR-T? And does that controversial drug even work? We discuss all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. Fi
STAT4 min readSociety
Opinion: Cannabidiol Confusion: Lofty Promises And Barriers To Research
The federal government's barriers to research on cannabis harm people who have medical conditions that lack therapies as well as those interested in exploring the proliferation of CBD products.
STAT4 min readPsychology
Opinion: With No Dementia Cure In Sight, It’s Time For Communities To Become Dementia Friendly
Dementia friendly projects can spark our imaginations about what makes a community a good place to live and show us how to learn from people with dementia and their caregivers.
STAT7 min read
Opinion: Novartis Violated FDA’s Sacred Principle: In God We Trust, All Others Must Bring Data
My experience in more than 40 years of developing and evaluating medical products, and two years working at the FDA, has convinced me that it's essential to have a second…
STAT6 min readTech
With Brain Trauma, Surgeons Don’t Always Know If An Operation Will Help. Could AI Change That?
Can AI be relied on to guide treatment of TBI patients, when the consequences of a wrong decision are so catastrophic?
STAT7 min readTech
One Health Care Startup At A Time, This Venture Capitalist Wants To Harness The Investing Power Of Women
“If women want specific companies in the world that address their needs, the only way to do that is for women to become the investors."
STAT2 min readScience
Novartis Ousted Top Scientists Over Manipulation Of Data For Gene Therapy
Novartis dismissed the top two scientists at its gene therapy division shortly after the company’s CEO learned of internal data falsification that has since snowballed into a damaging scandal.

More Publications

…Or Discover Something New
Browse Articles